FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/102200 [Registered on: 27/01/2026] Trial Registered Prospectively
Last Modified On: 27/01/2026
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   study of analysing bleb morphology after trabeculectomy using anterior segment Optical Coherence Tomography 
Scientific Title of Study   analysing bleb morphology after trabeculectomy using anterior segment Optical Coherence Tomography 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSamra wahaj Fatima  
Designation  Glucoma Fellows 
Affiliation  Nethradhama Super Speciality Eye Hospital  
Address  256/14, KANAKAPURA MAIN ROAD, JAYANAGAR 7TH BLOCK, BENGALURU, KARNATAKA

Bangalore
KARNATAKA
560070
India 
Phone  8374016816  
Fax    
Email  wjsam19@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrSamra wahaj Fatima  
Designation  Glucoma Fellows 
Affiliation  Nethradhama Super Speciality Eye Hospital  
Address  256/14, KANAKAPURA MAIN ROAD, JAYANAGAR 7TH BLOCK, BENGALURU, KARNATAKA


KARNATAKA
560070
India 
Phone  8374016816  
Fax    
Email  wjsam19@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Asha MS 
Designation  Glaucoma Senior Consultant  
Affiliation  Nethradhama Super Speciality Eye Hospital  
Address  256/14, KANAKAPURA MAIN ROAD, JAYANAGAR 7TH BLOCK, BENGALURU, KARNATAKA

Bangalore
KARNATAKA
560070
India 
Phone  9845373709  
Fax    
Email  drashamag@yahoo.co.uk  
 
Source of Monetary or Material Support  
256/14, Nethradhama Super Speciality Eye Hospital, Kanakapura main road, Jayanagar 7th block, Bengaluru Ba 
 
Primary Sponsor  
Name  Nethradhama Super Speciality Eye Hospital  
Address  256/14, Nethradhama Super Speciality Eye Hospital, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore  
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSamra wahaj Fatima   Nethradhama Super Speciality Eye Hospital  256/14, Department of Phacorefractive surgery, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore KARNATAKA Bangalore KARNATAKA Bangalore KARNATAKA Bangalore KARNATAKA
Bangalore
KARNATAKA 
83740 16816

wjsam19@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H258||Other age-related cataract, (2) ICD-10 Condition: H408||Other glaucoma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  84.00 Year(s)
Gender  Both 
Details  Post-trabeculectomy patients with primary glaucoma (open angle/angle closure)
underwent surgery when-uncontrolled on maximal medical treatment.
Baseline IOP was considered as an average of minimum two measurements, atleast two weeks apart. They were measured during different times of the day
 
 
ExclusionCriteria 
Details  Patients with significant conjunctival scarring,ocular surface disease affecting imaging ,secondary glaucoma and congenital glaucoma.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary outcomes -determining the functionality of filtering bleb  Follow up - day 1, 1 week, 6 weeks ,6 months 
 
Secondary Outcome  
Outcome  TimePoints 
determine success of trabeculectomy  Follow up - day 1, 1 week, 6 weeks ,6 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Methodology

This prospective observational and descriptive study will be approved by the Institutional Ethics Committee of Nethradhama Eye Hospital and will adhere to the tenets of the Declaration of Helsinki. Verbal and written informed consent will be obtained from all patients participating in the study.

Surgical Procedure

Following creation of a fornix based conjunctival flap a sponge soaked in Mitomycin C at a concentration of two hundred micrograms was applied under the conjunctiva for a duration of two minutes taking care that the Mitomycin C soaked sponge did not come in contact with the edge of the conjunctival flap. A partial thickness rectangular scleral flap was created followed by creation of a sclerostomy measuring two by two millimeters using scissors or Kelly punch. Closure of the scleral flap was performed using two side permanent sutures and one apical releasable ten zero nylon suture. The conjunctiva was closed using ten zero nylon sutures. Postoperatively antibiotic and steroid eye drops were administered in a tapering dose over a period of two months.

Imaging and Evaluation of Filtering Bleb

All blebs will be imaged using slit lamp photography under standardized illumination and magnification settings. All blebs will also be imaged using anterior segment optical coherence tomography using the Cirrus HD OCT five hundred system manufactured by Carl Zeiss Dublin California United States using a standardized imaging protocol.

Optical coherence tomography is a high resolution tomographic and biomicroscopic imaging device designed for anterior segment imaging and measurement with an axial resolution of eighteen micrometers. The principle of imaging is based on low coherence interferometry using a thirteen hundred ten nanometer superluminescent light emitting diode. Similar to an ultrasound B scan the Cirrus OCT acquires multiple A scans and aligns them to construct two dimensional images.

Patients will be instructed to look downward and the upper eyelid will be gently elevated to expose the bleb adequately while ensuring that no pressure is exerted on the globe or the bleb. Two scans namely radial and tangential will be obtained through the point of maximum bleb elevation.

Assessment Parameters

Anterior segment optical coherence tomography images will be evaluated by a single trained observer who will be masked to the clinical data. Blebs will be assessed qualitatively for bleb height bleb wall thickness in millimeters bleb wall reflectivity categorized as low medium or high and bleb pattern classified as uniform or multiform. Scleral flap configuration measured in millimeters will also be evaluated. Additional features assessed include the scleral flap morphology and the route of aqueous flow beneath the scleral flap.

 
Close